Rockwell Medical is a biopharmaceutical company that focuses on developing and providing innovative treatments for patients with chronic kidney disease and end-stage renal disease
The company specializes in therapies aimed at addressing the complications associated with these conditions, particularly iron deficiency anemia. Rockwell Medical is engaged in the research and development of solutions that enhance the quality of life for patients undergoing dialysis and other renal care, aiming to improve patient outcomes through effective medical interventions.
Companies Reporting Before The Bell • Creative Realities (NASDAQCREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQSGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.
Gainers ProMIS Neurosciences, Inc. (NASDAQPMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.
Gainers PainReform Ltd. (NASDAQPRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.
